Dr. Michael Barry Ginsberg, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 800 Washington St, Norwood, MA 02062 Phone: 617-733-9266 |
News Archive
Immunomedics Inc. today announced that clinical trial results from the Phase IIb EMBLEM study of epratuzumab, a monoclonal antibody targeting CD22, in patients with moderate-severe systemic lupus erythematosus were presented at the 2010 annual Congress of the European League Against Rheumatism in Rome, Italy.
The 2010 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) brings together leading allergists and immunologists from around the world.
In a year when COVID-19 threatens the health and well-being of everyone on the planet, the seventy-fourth session of the World Health Assembly (WHA) will stress the urgency of ending the current pandemic and preventing the next one by building a healthier, safer and fairer world.
One of the most harrowing effects of COVID-19 is severe damage to the lungs, which makes breathing hard or impossible for those who're severely affected.
Young school-aged children hurting themselves in playgrounds during summer is a leading cause of visits to hospital emergency rooms - second only to cycling mishaps - according to data released today by a national health organization.
› Verified 6 days ago